Toward knowing the whole human: Next-generation sequencing for personalized medicine

Personalized Medicine

Volumn 8, Issue 4, 2011, Pages 483-491

  Toma, Ian ^a   St Laurent III, Georges ^b,c   McCaffrey, Timothy A ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c St Laurent Institute   (United States)

Author keywords

genomic medicine; microarrays; next generation sequencing; personalized medicine; RNA sequencing

Indexed keywords

TRANSCRIPTOME;

ARTICLE; EPIGENETICS; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HUMAN; HUMAN GENOME; MICROARRAY ANALYSIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RNA EDITING; RNA SEQUENCE; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79960963630     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.11.27     Document Type: Article

References (43)

1. Ozdemir V, Suarez-Kurtz G, Stenne R et al. Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of 'edge effect' and cultivating an ethical bridge between omics innovations and society. Omics 13(1), 43-61 (2009).
2. Lander ES. Initial impact of the sequencing of the human genome. Nature 470(7333), 187-197 (2011).
3. St Laurent G 3rd, Wahlestedt C. Noncoding RNAs: couplers of analog and digital information in nervous system function? Trends Neurosci. 30(12), 612-621 (2007). (Pubitemid 350101854)
4. Mattick JS, Amaral PP, Dinger ME, Mercer TR, Mehler MF. RNA regulation of epigenetic processes. Bioessays 31(1), 51-59 (2009).
5. Kapranov P, Cheng J, Dike S et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316(5830), 1484-1488 (2007). (Pubitemid 46906616)
6. Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum. Mol. Genet. 19(R2), R152-R161 (2010).
7. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11(9), 597-610 (2010).
8. van Bakel H, Nislow C, Blencowe BJ, Hughes TR. Most 'dark matter' transcripts are associated with known genes. PLoS Biol. 8(5), e1000371 (2010).
9. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-seq. Nat. Methods 5(7), 621-628 (2008). (Pubitemid 351911867)
10. Debey S, Zander T, Brors B, Popov A, Eils R, Schultze JL. A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Genomics 87(5), 653-664 (2006).
11. Li L, Ying L, Naesens M et al. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol. Genomics 32(2), 190-197 (2008). (Pubitemid 351186326)
12. Tazi J, Bakkour N, Stamm S. Alternative splicing and disease. Biochim. Biophys. Acta 1792(1), 14-26 (2009).
13. Eriksson M, Brown WT, Gordon LB et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423(6937), 293-298 (2003). (Pubitemid 40852699)
14. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. Proliferating cells express mRNAs with shortened 3́ untranslated regions and fewer microRNA target sites. Science 320(5883), 1643-1647 (2008). (Pubitemid 351931255)
15. Taft RJ, Glazov EA, Lassmann T, Hayashizaki Y, Carninci P, Mattick JS. Small RNAs derived from snoRNAs. RNA 15(7), 1233-1240 (2009).
16. Ubeda F, Wilkins JF. Imprinted genes and human disease: an evolutionary perspective. Adv. Exp. Med. Biol. 626, 101-115 (2008).
17. Maher B. Personal genomes: the case of the missing heritability. Nature 456(7218), 18-21 (2008).
18. Edwards AO. Genetics of age-related macular degeneration. Adv. Exp. Med. Biol. 613, 211-219 (2008).
19. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. Rare variants create synthetic genome-wide associations. PLoS Biol. 8(1), e1000294 (2010).
20. Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature 461(7265), 747-753 (2009).
21. Lettre G, Jackson AU, Gieger C et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat. Genet. 40(5), 584-591 (2008). (Pubitemid 351601214)
22. Weedon MN, Lango H, Lindgren CM et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat. Genet. 40(5), 575-583 (2008). (Pubitemid 351601210)
23. Gudbjartsson DF, Walters GB, Thorleifsson G et al. Many sequence variants affecting diversity of adult human height. Nat. Genet. 40(5), 609-615 (2008). (Pubitemid 351601211)
24. Lango Allen H, Estrada K, Lettre G et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467(7317), 832-838 (2010).
25. Yeo RA, Gangestad SW, Liu J, Calhoun VD, Hutchison KE. Rare copy number deletions predict individual variation in intelligence. PLoS ONE 6(1), e16339 (2011).
26. Gai X, Xie HM, Perin JC et al. Rare structural variation of synapse and neurotransmission genes in autism. Mol. Psychiatry (2011) (Epub ahead of print).
27. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet. 11(6), 415-425 (2010).
28. Dracheva S, Chin B, Haroutunian V. Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport. 19(3), 379-382 (2008). (Pubitemid 351322981)
29. Dracheva S, Lyddon R, Barley K, Marcus SM, Hurd YL, Byne WM. Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral trait. Neuropsychopharmacology 34(10), 2237-2251 (2009).
30. George CX, Gan Z, Liu Y, Samuel CE. Adenosine deaminases acting on RNA, RNA editing, and interferon action. J. Interferon Cytokine Res. 31(1), 99-117 (2011).
31. Peng PL, Zhong X, Tu W et al. ADAR2- dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron 49(5), 719-733 (2006). (Pubitemid 43290131)
32. Blanc V, Davidson NO. APOBEC-1-mediated RNA editing. Wiley Interdiscip. Rev. Syst. Biol. Med. 2(5), 594-602 (2010).
33. Flusberg BA, Webster DR, Lee JH et al. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat. Methods 7(6), 461-465 (2010).
34. Mamanova L, Andrews RM, James KD et al. FRT-seq: amplification-free, strand-specific transcriptome sequencing. Nat. Methods 7(2), 130-132 (2010).
35. Metzker ML. Sequencing technologies - the next generation. Nat. Rev. Genet. 11(1), 31-46 (2010).
36. Roach JC, Glusman G, Smit AFA et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328(5978), 636-639 (2010).
37. Schulze WX, Usadel BR: Quantitation in mass-spectrometry-based proteomics. Annu. Rev. Plant Biol. 61(1), 491-516 (2010).
38. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM: Metabolomics: a global biochemical approach to drug response and disease. Annu. Rev. Pharmacol. Toxicol. 48(1), 653-683 (2008). (Pubitemid 351738167)
39. Cahan P, Rovegno F, Mooney D, Newman JC, St Laurent G 3rd, McCaffrey TA. Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardization. Gene 401(1-2), 12-18 (2007). (Pubitemid 47379509)
40. Yan Q. Toward the integration of personalized and systems medicine: challenges, opportunities and approaches. Pers. Med. 8(1), 1-4 (2011).
41. Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333), 204-213 (2011).
42. Pang T. Germs, genomics and global public health: how can advances in genomic sciences be integrated into public health in the developing world to deal with infectious diseases? Hugo J. 3(1-4), 5-9 (2009).
43. Burke W, Burton H, Hall AE et al. Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and 'personalized' medicine? Genet. Med. 12(12), 785-791 (2010).